Abstracts

Guidelines & Instructions

Best Oral Presentations

This would take the form of a 3 minute pre-recorded presentation of your research, followed by a 3 minute live discussion between you as speaker and a moderator.

There will be audience questions via a chat facility with questions selected by the moderator.

Please keep the number of slides to a minumum - we would suggest no more than three. We recommend that you:

  • start with your conclusion slide
  • support your conclusions with the most relevant data
  • end with a take home message

Please click here for the PowerPoint template.

Oral Presentations

Your 3 minute pre-recorded presentation should take the form of an audio recording accompanied by one single slide. This programme includes a zoom-in facility which allows the viewer to select the different features of the slide and hear the accompanying audio.

There will be audience questions via a chat facility, and we would ask you to be available to give answers when you receive a question notification.

Please click here for the PowerPoint templates (chose one from the two available).

e-Posters

Your presentation should take the form of one single PowerPoint slide.

There will be audience questions via a chat facility, and we would ask you to be available to give answers when you receive a question notification.

Please click here for the PowerPoint template (chose one from the two available).

Review Process

The abstract submission system closed on 30 July 2020. This abstract receipt deadline will remain firm and any abstracts received after the deadline will not be accepted.

The authors have been informed of acceptance/rejection of their abstract by email on 22 September and 05 October.

A platform to record and upload abstracts will be available from 20 October, an individual link will be sent along with the guidelines. This process has been delayed due to the COVID-19 situation.    

Still have questions? See our FAQ below.

Abstract notifications have been sent to the presenting authors on 22 September and 05 October. This is later than was planned due to the COVID-19 situation.

No, you will not be able to make changes to your abstract once submitted. However, corrections can be highlighted on your poster if necessary.

No, late-breaking abstracts won’t be accepted.

Yes, all presenters of accepted abstracts are required to present their poster during the digital event. More details of how to submit your presentation will follow by email in the coming weeks. 

Yes, the abstract presenter must register for the congress in order to present his work.

Yes, all accepted abstracts will be published in the Abstract Book which can be accessed via our website just before the congress.

Submitting an abstract also certifies that at the time of submission, the scientific material found within the abstract has not been presented at any other meeting and will not be published in any form other than abstract form prior to LIVES Digital 2020. If you have plans to do so, please contact us at scientific@cyim.com in order that your abstract may be withdraw from our event.

Although you may withdraw your abstract and decide not present it during the LIVES 2020 digital congress please note that this will mean you will not be able to submit it again for LIVES 2021, as the abstract will have already been published in the Abstract Book 2020.

LIVES Digital 2020 Abstracts Awards

Three N&AHP Best Abstract Awards

The N&AHP Best Abstract Awards include:

  • one free registration to LIVES 2021 (core congress) plus travel and accommodation (up to 1,000 Euro).
  • two runners-up will receive free registrations to LIVES 2021 (core congress).

Abstracts selected by the jury will be presented in our session N&AHP research & networking: What's new? during the Digital Congress on Monday 07 December between 14:00-16:15

  1. Cross-sectional validity of the Chelsea Critical Care Physical Assessment tool (CPAx) in critically ill adults - S. Eggmann (Bern, Switzerland)
  2. Impact of a nurse-led family support intervention for families of critically ill persons: A mixed methods study - P. Massarotto (Zürich, Switzerland)
  3. The role of the physiotherapy team in a multidisciplinary management of pronation in critically ill COVID-19 patients - S. Ceruti (Lugano, Switzerland)

One ISF Abstract Award

The ISF Abstract Award includes a free registration to LIVES 2021 (core congress) plus travel and accommodation (up to 500 Euro).

Abstract selected by the jury will be presented in our session Best Oral Presentations 1 during the Congress on Monday 07 December at 14:00-15:00

  1. Involvement of β-adrenergic modulation in lymphocyte balance during experimental septic shock - M. Durand (Nancy, France)

Thirty Best Abstracts

Presenters of the 30 best abstracts will receive an award, including one free registration to LIVES 2021 (core congress) plus travel and accommodation (up to 1,000 Euro).

Abstracts selected by the jury will be presented in our sessions Best Oral Presentations 1-2-3 during the Congress between 07-09 December

  1. Identification of novel clinical subphenotypes in patients with community acquired pneumonia. A derivation study - Aquino Esperanza Jose, Spain
  2. Effects of high flow nasal cannula (HFNC) in patients with sepsis and septic shock of extrapulmonary origin - Basile Maria Cristina, Italy
  3. (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture - based diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep) - Bloos Frank, Germany
  4. Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Patients With Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia by Geographic Region - Chen Luke F, United States of America
  5. H and L-subphenotype prevalence in ARDS patients with and without SARS-CoV-2 - Chotalia Minesh, United Kingdom
  6. Impact of oral chlorhexidine de-adoption and implementation of an oral care bundle on mortality for mechanically ventilated adults: A stepped wedge cluster randomized controlled trial - Dale Craig, Canada
  7. Temporary transvenous diaphragm neurostimulation in mechanically ventilated patients – preliminary results from a randomized controlled trial - Dres Martin, France
  8. Involvement of β-adrenergic modulation in lymphocyte balance during experimental septic shock - Durand Manon, France
  9. Cross-sectional validity of the Chelsea Critical Care Physical Assessment tool (CPAx) in critically ill adults - Eggmann Sabrina, Switzerland
  10. Role of endothelial micro RNA 155 on capillary leakage in systemic inflammation - Etzrodt Valerie, Germany
  11. The association between the Sequential Organ Failure Assessment scores in particular systems and intensive care unit mortality in patients ≥80 years old – a prospective cohort study - Fronczek Jakub, Poland
  12. Dysphagia and evolution during COVID-19 pandemic in critically ill patients. A multidisciplinary challenge for healthcare workers - Glotta Andrea, Switzerland
  13. Where did all the women go? The underrepresentation of women in educational resources during COVID-19 - Hall Tanya, United Kingdom
  14. Biological subphenotypes of acute respiratory distress syndrome show prognostic enrichment in the general ICU population - Heijnen Nanon, Netherlands
  15. Vasoactive effects of vanilloids in progressive peritoneal sepsis - Horak Jan, Czech Republic
  16. PEEP titration with electrical impedance tomography and pressure-volume curve: a randomized trial in ARDS patients - Hsu Hui Ju, Taiwan
  17. Long-term developmental impact of withholding parenteral nutrition in paediatric-ICU: a 4-year follow-up of the PEPaNIC randomized controlled trial - Jacobs An, Belgium
  18. Moderately prolonged permissive hypotension results in reversible cerebral metabolic perturbations evaluated by intracerebral microdialysis - Jakobsen Rasmus Peter, Denmark
  19. Randomized Clinical Trial Comparing Gram Stain-guided Initial Antibiotic Treatment with Guidelines-based Treatment in Patients with Ventilator-associated Pneumonia: GRam stain-guided Antibiotics ChoicE for Ventilator-Associated Pneumonia (GRACE-VAP) Trial - Jumpei Yosimura, Japan
  20. Effects of prone positioning on venous return in patients with acute respiratory distress syndrome - Lai Christopher, France
  21. Circulating bioactive adrenomedullin as a marker of sepsis, septic shock and critical illness - Lundberg Oscar H M, Sweden
  22. Epidemiology and risk factors of ventilator-associated pneumonia in COVID-19 patients: a propensity-score matched analysis - Martinez Martinez Maria, Spain
  23. The use of high flow nasal cannula oxygen around end of life: indications, complications, outcomes - Metaxa Victoria, United Kingdom
  24. Relationship between obesity and ventilator-associated pneumonia: a planned ancillary study of the NUTRIREA-2 randomized controlled trial - Nseir Saad, France
  25. Different renal trajectories and outcomes after Acute Kidney Injury in Intensive Care Unit: a 5-years prospective cohort study- Orieux Arthur, France
  26. “Is this a good time to talk?” Improving telephone communication between junior doctors and relatives of patients in ICU during the COVID-19 pandemic - Rahim Anika, United Kingdom
  27. Validation of a novel non-invasive continuous method to monitor end expiratory lung volume based on CO2 kinetics - Sánchez Giralt Juan Antonio, Spain
  28. Impact of sex and ICU treatment duration on creatinine and potassium excretion in critically ill patients - Van Bakelen-Knip Martine, Netherlands
  29. Incidence and risk factors of deep vein thrombosis after extracorporeal membrane oxygenation - van Minnen Olivier, Netherlands
  30. Evidence of Heart Decoupling Between Work, Metabolism and Microcirculation in Endotoxic Shock : [11C] Acetate PET Approach - Visinoni Nicolas, France